245 related articles for article (PubMed ID: 12459027)
1. Synthesis and antimycobacterial activity of pyrazine and quinoxaline derivatives.
Seitz LE; Suling WJ; Reynolds RC
J Med Chem; 2002 Dec; 45(25):5604-6. PubMed ID: 12459027
[TBL] [Abstract][Full Text] [Related]
2. Quantitative structure-activity relationships for the in vitro antimycobacterial activity of pyrazinoic acid esters.
Bergmann KE; Cynamon MH; Welch JT
J Med Chem; 1996 Aug; 39(17):3394-400. PubMed ID: 8765523
[TBL] [Abstract][Full Text] [Related]
3. Substituted N-Phenylpyrazine-2-carboxamides: synthesis and antimycobacterial evaluation.
Dolezal M; Zitko J; Kesetovicová D; Kunes J; Svobodová M
Molecules; 2009 Oct; 14(10):4180-9. PubMed ID: 19924056
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and anti-mycobacterial evaluation of some pyrazine-2-carboxylic acid hydrazide derivatives.
Abdel-Aziz M; Abdel-Rahman HM
Eur J Med Chem; 2010 Aug; 45(8):3384-8. PubMed ID: 20488590
[TBL] [Abstract][Full Text] [Related]
5. Antimycobacterial activity of new quinoxaline-2-carbonitrile and quinoxaline-2-carbonitrile 1,4-di-N-oxide derivatives.
Ortega MA; Montoya ME; Jaso A; Zarranz B; Tirapu I; Aldana I; Monge A
Pharmazie; 2001 Mar; 56(3):205-7. PubMed ID: 11265583
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antimycobacterial evaluation of N-substituted 3-aminopyrazine-2,5-dicarbonitriles.
Zitko J; Jampílek J; Dobrovolný L; Svobodová M; Kuneš J; Doležal M
Bioorg Med Chem Lett; 2012 Feb; 22(4):1598-601. PubMed ID: 22281187
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and Biological Evaluation of N-Alkyl-3-(alkylamino)-pyrazine-2-carboxamides.
Semelkova L; Konecna K; Paterova P; Kubicek V; Kunes J; Novakova L; Marek J; Naesens L; Pesko M; Kralova K; Dolezal M; Zitko J
Molecules; 2015 May; 20(5):8687-711. PubMed ID: 26007174
[TBL] [Abstract][Full Text] [Related]
8. Antimycobacterial activity of a series of pyrazinoic acid esters.
Cynamon MH; Klemens SP; Chou TS; Gimi RH; Welch JT
J Med Chem; 1992 Apr; 35(7):1212-5. PubMed ID: 1560435
[TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis, Antimycobacterial Evaluation, and In Silico Studies of 3-(Phenylcarbamoyl)-pyrazine-2-carboxylic Acids.
Semelková L; Janošcová P; Fernandes C; Bouz G; Janďourek O; Konečná K; Paterová P; Navrátilová L; Kuneš J; Doležal M; Zitko J
Molecules; 2017 Sep; 22(9):. PubMed ID: 28880230
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antimycobacterial evaluation of N-substituted 5-chloropyrazine-2-carboxamides.
Servusová B; Vobicková J; Paterová P; Kubíček V; Kuneš J; Doležal M; Zitko J
Bioorg Med Chem Lett; 2013 Jun; 23(12):3589-91. PubMed ID: 23659859
[TBL] [Abstract][Full Text] [Related]
11. Pyrazinoic acid esters with broad spectrum in vitro antimycobacterial activity.
Cynamon MH; Gimi R; Gyenes F; Sharpe CA; Bergmann KE; Han HJ; Gregor LB; Rapolu R; Luciano G; Welch JT
J Med Chem; 1995 Sep; 38(20):3902-7. PubMed ID: 7562923
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, antimycobacterial and antifungal evaluation of 3-arylaminopyrazine-2,5-dicarbonitriles.
Palek L; Dvorák J; Svobodová M; Buchta V; Jampílek J; Dolezal M
Arch Pharm (Weinheim); 2008 Jan; 341(1):61-5. PubMed ID: 18072243
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, antimycobacterial and antifungal evaluation of some new 1-ethyl-5-(hetero)aryl-6-styryl-1,6-dihydropyrazine-2,3-dicarbonitriles.
Verbitskiy EV; Slepukhin PA; Kravchenko MA; Skornyakov SN; Evstigneeva NP; Kungurov NV; Zil'berberg NV; Rusinov GL; Chupakhin ON; Charushin VN
Bioorg Med Chem Lett; 2015 Feb; 25(3):524-8. PubMed ID: 25556103
[TBL] [Abstract][Full Text] [Related]
14. Ureidopyrazine Derivatives: Synthesis and Biological Evaluation as Anti-Infectives and Abiotic Elicitors.
Bouz G; Juhás M; Niklová P; Janďourek O; Paterová P; Janoušek J; Tůmová L; Kovalíková Z; Kastner P; Doležal M; Zitko J
Molecules; 2017 Oct; 22(10):. PubMed ID: 29065539
[TBL] [Abstract][Full Text] [Related]
15. Lipophilic N-acylpyrazinamide derivatives: synthesis, physicochemical characterization, liposome incorporation, and in vitro activity against Mycobacterium avium-intracellulare.
Liu ZZ; Guo XD; Straub LE; Erdos G; Prankerd RJ; Gonzalez-Rothi RJ; Schreier H
Drug Des Discov; 1991 Nov; 8(1):57-67. PubMed ID: 1810412
[TBL] [Abstract][Full Text] [Related]
16. 3-Substituted N-Benzylpyrazine-2-carboxamide Derivatives: Synthesis, Antimycobacterial and Antibacterial Evaluation.
Semelková L; Janďourek O; Konečná K; Paterová P; Navrátilová L; Trejtnar F; Kubíček V; Kuneš J; Doležal M; Zitko J
Molecules; 2017 Mar; 22(3):. PubMed ID: 28335571
[TBL] [Abstract][Full Text] [Related]
17. N1-Hetaryl substituted pyridine- and pyrazinecarboxamidrazones with antimycobacterial activity.
Ranft D; Lehwark-Yvetot G; Schaper KJ; Büge A
Arch Pharm (Weinheim); 1997 Jun; 330(6):169-72. PubMed ID: 9297448
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antimycobacterial evaluation of substituted pyrazinecarboxamides.
Dolezal M; Cmedlova P; Palek L; Vinsova J; Kunes J; Buchta V; Jampilek J; Kralova K
Eur J Med Chem; 2008 May; 43(5):1105-13. PubMed ID: 17870211
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antimycobacterial activity of N'-[(E)-(monosubstituted-benzylidene)]-2-pyrazinecarbohydrazide derivatives.
Vergara FM; Lima CH; Henriques Md; Candéa AL; Lourenço MC; Ferreira Mde L; Kaiser CR; de Souza MV
Eur J Med Chem; 2009 Dec; 44(12):4954-9. PubMed ID: 19765866
[TBL] [Abstract][Full Text] [Related]
20. Pyrazinoic acid and its n-propyl ester inhibit fatty acid synthase type I in replicating tubercle bacilli.
Zimhony O; Vilchèze C; Arai M; Welch JT; Jacobs WR
Antimicrob Agents Chemother; 2007 Feb; 51(2):752-4. PubMed ID: 17101678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]